Archive

Gastrointestinal Cancers Symposium Daily News Archive

The Gastrointestinal Cancers Symposium Daily News is the official news source for the Gastrointestinal Cancers Symposium, providing expert perspectives on controversial topics and session highlights. Articles include physician-authored “Expert Editorials” on current clinical issues in oncology, interviews with Meeting attendees, and recaps of key sessions and presentations. Content is current as of the Meeting date and may not reflect the most recent data.

January 23, 2018

Two studies leveraging highly novel approaches show considerable merit for enhancing colorectal cancerscreening and improving the efficiency of surveillance.

Read more
January 23, 2018

A General Session held January 20 during the 2018 Gastrointestinal Cancers Symposium provided a comprehensive overview of early-onset CRC, including results of a study focused on the age distribution of tumor gene expression in patients with stage II/III colon cancer.

Read more
January 23, 2018

Merit Awards are awarded to fellows/oncology trainees whose research is addressed in high-quality abstracts submitted to an ASCO-sponsored or cosponsored meeting and recognized for its scientific merit.

Read more

January 21, 2018

CheckMate-142 is designed to determine whether nivolumab alone or in combination with other anticancer drugs can yield meaningful reductions in tumor size in patients with colorectal cancer that has metastasized or recurred following at least one prior line of therapy.

Read more

January 20, 2018

The phase III CELESTIAL trial met its primary endpoint by demonstrating a survival advantage with cabozantinib in patients with advanced hepatocellular carcinoma (HCC) that progressed following prior systemic therapy.

Read more

January 20, 2018

Use of the oral fluoropyrimidine-based chemotherapy S-1 in combination with gemcitabine yielded similar efficacy and a more favorable and convenient tolerability profile versus cisplatin and gemcitabine in patients with advanced biliary tract cancer.

Read more
January 20, 2018

Results of the randomized controlled TACTICS trial demonstrate that transcatheter arterial chemoembolization (TACE) in combination with sorafenib significantly improved progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC), as compared with TACE alone.

Read more

January 20, 2018

Five important talks delivered the morning of January 19 during the 2018 Gastrointestinal Cancers Symposium covered diverse topics that provide insight into future diagnostic, management, and research directions in hepatocellular carcinoma

Read more

January 19, 2018

Results of the global, randomized, double-blind, placebo-controlled, phase III RAINFALL trial established the statistical benefit of ramucirumab added to standard chemotherapy for patients with previously untreated metastatic gastric or gastroesophageal junction adenocarcinoma.

Read more

January 19, 2018

Two studies that investigated the ways in which neoadjuvant chemoradiation therapy is delivered before surgery and how different parameters influence survival outcomes raise some questions and suggest that CRT may exert unintended consequences.

Read more

January 19, 2018

Final results of the randomized phase II CatuNeo trial conducted in patients with peritoneal carcinomatosis from gastric cancer provide mixed results.

Read more

January 19, 2018

Several presentations delivered on January 18 offered a look at how different regions identify and manage early gastric cancer around the world.

Read more
January 11, 2018

Dr. Paola Montenegro discusses recommended frontline therapies, pathways, and standard treatment possibilities for small bowel adenocarcinomas.

Read more
January 11, 2018

The challenges associated with treating gastrointestinal cancers are not isolated to the United States. 

Read more

January 11, 2018

The growing incidence of early-onset colorectal cancer is the topic of several presentations to be presented during the General Session, “Early-Onset Colorectal Cancer” on January 20.

Read more

January 11, 2018

Applications are now open for ASCO’s 2018 Quality Training Program (QTP), which prepares oncology providers to design, implement, and lead successful quality improvement activities in busy practice settings throughout 6 months of learning.

Read more

January 11, 2018

Researchers sought to find whether perioperative hepatic arterial infusion (HAI) pump chemotherapy is positively associated with overall survival in patients who had a complete resection of colorectal liver metastases

Read more

January 11, 2018

Dr. Daphna Y. Spiegel et al review the role of adjuvant therapy and the current treatment landscape for rectal cancer.

Read more

January 11, 2018

The joint position statement from AACR, ACS, ASCO, and NCI represents a unified strategy to foster cooperation across the cancer research community to ensure that all patients benefit from cancer research.

Read more

January 11, 2018

Dr. Vivian E. Strong and Dr. Ryan C. Fields discuss standards of care for varying stages of gastric cancer.

Read more